TY - JOUR
T1 - Associations of the COVID-19 burden and various comorbidities of different ethnic groups in Israel
T2 - a cross-sectional study
AU - Tarabeih, Mahdi
AU - Perelmutter, Ori
AU - Kitay-Cohen, Yona
AU - Amiel, Aliza
AU - Na’amnih, Wasef
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
PY - 2023/12
Y1 - 2023/12
N2 - Coronavirus disease (COVID-19) is highly transmissible between human beings. We examined differences in the core families with COVID-19 severity and mortality and comorbidities between Arab and Jews and explored the factors associated with COVID-19 severity and mortality to find a genetic component. A cross-sectional study was conducted among 2240 COVID-19 patients (> 18 years of age) randomly selected by online panels and questionnaires in the native language (Hebrew or Arabic) during March 2021–June 2022. Multivariable linear regression models were used to assess correlations with COVID-19 disease severity and mortality. Overall, 1549 (69%) were Arabs and 691 (31%) were Jews. The proportion of participants who died from COVID-19 was higher among Arabs compared with Jews (66% vs. 59%), P < 0.001. The mean number of deaths from COVID-19 and patients with severe COVID-19 was higher in ultra-Orthodox Jewish, non-academic core families and those who lived in the city residence compared with secular, academic core families and who live in the village residence, P < 0.001. A multivariable linear regression model showed a significant association between metabolic, kidney, cardiovascular, and respiratory diseases with COVID-19 severity (B coefficient − 0.43, B coefficient − 0.53, B coefficient − 0.53, B coefficient − 0.42, respectively) and COVID-19 mortality (B coefficient − 0.51, B coefficient − 0.64, B coefficient − 0.67, B coefficient − 0.34, respectively), P < 0.001. COVID-19 severity and mortality were highly associated with comorbidities, ethnicity, social and environmental factors. Furthermore, we believe that genetic factors also contribute to the increase in COVID-19 severity and mortality and the differences rates of these between Arabs and Jews in Israel.
AB - Coronavirus disease (COVID-19) is highly transmissible between human beings. We examined differences in the core families with COVID-19 severity and mortality and comorbidities between Arab and Jews and explored the factors associated with COVID-19 severity and mortality to find a genetic component. A cross-sectional study was conducted among 2240 COVID-19 patients (> 18 years of age) randomly selected by online panels and questionnaires in the native language (Hebrew or Arabic) during March 2021–June 2022. Multivariable linear regression models were used to assess correlations with COVID-19 disease severity and mortality. Overall, 1549 (69%) were Arabs and 691 (31%) were Jews. The proportion of participants who died from COVID-19 was higher among Arabs compared with Jews (66% vs. 59%), P < 0.001. The mean number of deaths from COVID-19 and patients with severe COVID-19 was higher in ultra-Orthodox Jewish, non-academic core families and those who lived in the city residence compared with secular, academic core families and who live in the village residence, P < 0.001. A multivariable linear regression model showed a significant association between metabolic, kidney, cardiovascular, and respiratory diseases with COVID-19 severity (B coefficient − 0.43, B coefficient − 0.53, B coefficient − 0.53, B coefficient − 0.42, respectively) and COVID-19 mortality (B coefficient − 0.51, B coefficient − 0.64, B coefficient − 0.67, B coefficient − 0.34, respectively), P < 0.001. COVID-19 severity and mortality were highly associated with comorbidities, ethnicity, social and environmental factors. Furthermore, we believe that genetic factors also contribute to the increase in COVID-19 severity and mortality and the differences rates of these between Arabs and Jews in Israel.
KW - COVID-19 burden
KW - Comorbidities
KW - Ethnic groups
KW - Genetic component
UR - http://www.scopus.com/inward/record.url?scp=85169320234&partnerID=8YFLogxK
U2 - 10.1007/s10238-023-01172-4
DO - 10.1007/s10238-023-01172-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37658247
AN - SCOPUS:85169320234
SN - 1591-8890
VL - 23
SP - 4891
EP - 4899
JO - Clinical and Experimental Medicine
JF - Clinical and Experimental Medicine
IS - 8
ER -